Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Biogen Inc (BIIB) vs Five Below Inc (FIVE) Price & Performance

Biogen IncTrade
Five Below IncTrade

Price performance (Past 24H)

Key statistics

Biogen Inc vs Five Below Inc — how do they compare? Biogen Inc trades at $191.9 (market cap $30.86B), while Five Below Inc trades at $190 (market cap $10.59B). The key difference: Biogen Inc is far larger — about 2.9× Five Below Inc's market cap, and Biogen Inc is trading nearer its 52-week high, Five Below Inc nearer its low. Which is the better fit depends on your goals.

BIIBFIVE
Market Cap
$30.86B$10.59B
Sector
HealthConsumer Staples
52-Week High
$216.63$247.71
52-Week Low
$122.68$131.94
Enterprise Value
$33.14B$11.48B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Biogen Inc

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021.

Read more on BIIB

About Five Below Inc

Five Below is a value-oriented retailer that operated 1,190 stores in the United States as of the end of fiscal 2021. Catering to teen and preteen consumers, stores feature a wide variety of merchandise, the vast majority of which is priced below $6. The assortment focuses on discretionary items in several categories, particularly leisure (such as sporting goods, toys, and electronics

Read more on FIVE